Next Generation Ingestible Sensors for Medication Adherence Measurement

Clinical trial NCT05592613 · COMPLETED

Trial details

NCT number: NCT05592613
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infection Adherence, Medication Adherence, Treatment Pre-Exposure Prophylaxis Antiretroviral Therapy

Start date: 2023-02-06
Primary completion: 2024-07-25
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.